bupropion has been researched along with Headache in 10 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested the efficacy of bupropion in the treatment of persons with pathological gambling (PG)." | 9.12 | Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. ( Allen, J; Argo, T; Arndt, S; Black, DW; Coryell, WH; Forbush, KT; Perry, P; Shaw, MC, 2007) |
| " Each drug, besides its therapeutic effect, creates the risk of adverse reactions which number and severity is not always accepted by the patient." | 5.39 | [Safety of nicotine addiction treatment]. ( Cieślewicz, A; Jabłecka, A; Korzeniowska, K, 2013) |
| "We tested the efficacy of bupropion in the treatment of persons with pathological gambling (PG)." | 5.12 | Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. ( Allen, J; Argo, T; Arndt, S; Black, DW; Coryell, WH; Forbush, KT; Perry, P; Shaw, MC, 2007) |
| "Outpatients with moderate to severe major depressive disorder (DSM-IV) received bupropion SR (100-300 mg/day) or sertraline (50-200 mg/day) for 16 weeks." | 5.08 | Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. ( Ascher, JA; Hughes, AR; Johnston, JA; Kavoussi, RJ; Segraves, RT, 1997) |
| "Bupropion has a comparable safety and efficacy profile with methylphenidate in children and adolescents with ADHD." | 2.77 | Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study. ( Akhondzadeh, S; Ashrafi, M; Jafarinia, M; Khajavi, D; Modabbernia, A; Mohammadi, MR; Tabrizi, M; Yadegari, N, 2012) |
| "For a population with a yearly recurrence rate of 30%, the NNTB is 8 (95% CI 6 to 12)." | 2.61 | Second-generation antidepressants for preventing seasonal affective disorder in adults. ( Forneris, CA; Gartlehner, G; Gaynes, BN; Greenblatt, A; Lux, LJ; Morgan, LC; Nussbaumer-Streit, B; Van Noord, MG; Winkler, D; Wipplinger, J, 2019) |
| "To assess the risk of headache associated with commonly prescribed antidepressant medications and to examine the impact of medication class, pharmacodynamics and dosage on risk of headache." | 2.58 | Meta-analysis: Second generation antidepressants and headache. ( Bloch, MH; Olten, B; Telang, S; Walton, C, 2018) |
| "Bupropion is a cytochrome p450 2D6 inhibitor and care must be taken when coprescribing with drugs cleared by this enzyme and when coprescribing with drugs that lower seizure threshold." | 2.43 | Bupropion. ( Wilkes, S, 2006) |
| "Study data demonstrate that seizure incidence, which is a concern with high-dose IR, is substantially lower with the new SR formulation." | 2.40 | Bupropion sustained release: side effect profile. ( Settle, EC, 1998) |
| " Each drug, besides its therapeutic effect, creates the risk of adverse reactions which number and severity is not always accepted by the patient." | 1.39 | [Safety of nicotine addiction treatment]. ( Cieślewicz, A; Jabłecka, A; Korzeniowska, K, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Telang, S | 1 |
| Walton, C | 1 |
| Olten, B | 1 |
| Bloch, MH | 1 |
| Gartlehner, G | 1 |
| Nussbaumer-Streit, B | 1 |
| Gaynes, BN | 1 |
| Forneris, CA | 1 |
| Morgan, LC | 1 |
| Greenblatt, A | 1 |
| Wipplinger, J | 1 |
| Lux, LJ | 1 |
| Van Noord, MG | 1 |
| Winkler, D | 1 |
| Korzeniowska, K | 1 |
| Cieślewicz, A | 1 |
| Jabłecka, A | 1 |
| Jafarinia, M | 1 |
| Mohammadi, MR | 1 |
| Modabbernia, A | 1 |
| Ashrafi, M | 1 |
| Khajavi, D | 1 |
| Tabrizi, M | 1 |
| Yadegari, N | 1 |
| Akhondzadeh, S | 1 |
| Wilkes, S | 1 |
| Menza, MA | 1 |
| Dobkin, RD | 1 |
| Marin, H | 1 |
| Black, DW | 1 |
| Arndt, S | 1 |
| Coryell, WH | 1 |
| Argo, T | 1 |
| Forbush, KT | 1 |
| Shaw, MC | 1 |
| Perry, P | 1 |
| Allen, J | 1 |
| Kavoussi, RJ | 1 |
| Segraves, RT | 1 |
| Hughes, AR | 1 |
| Ascher, JA | 1 |
| Johnston, JA | 1 |
| Pinsker, W | 1 |
| Settle, EC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Bupropion Versus Placebo in the Treatment of Pathological Gambling[NCT00055393] | 80 participants (Actual) | Interventional | 2002-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for bupropion and Headache
| Article | Year |
|---|---|
Meta-analysis: Second generation antidepressants and headache.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Citalopram; Depression; Double- | 2018 |
Second-generation antidepressants for preventing seasonal affective disorder in adults.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Diarrhea; Headache; Humans; Incidence; N | 2019 |
Bupropion.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dizziness; Headache; Humans; Models, Biological | 2006 |
Bupropion sustained release: side effect profile.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Delayed-Actio | 1998 |
4 trials available for bupropion and Headache
| Article | Year |
|---|---|
Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit | 2012 |
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsyc | 2007 |
Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Diagnostic and Statistical Manu | 2007 |
Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Bupropion; Delayed | 1997 |
2 other studies available for bupropion and Headache
| Article | Year |
|---|---|
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Huma | 2013 |
Treatment of headache with bupropion.
Topics: Bupropion; Chronic Disease; Dopamine Uptake Inhibitors; Headache; Humans; Recurrence | 1998 |